No Data
No Data
Express News | Northwest Biotherapeutics Announces $5 Million Convertible Note Financing and Standby Facility for up to $50 Million Additional Financing
Press Release: Northwest Biotherapeutics Announces $5 Million Convertible Note Financing and Standby Facility for Up to $50 Million Additional Financing
Northwest Biotherapeutics | 10-Q: Q3 2024 Earnings Report
Northwest Biotherapeutics | 10-Q: Q2 2024 Earnings Report
Northwest Biotherapeutics | 10-Q: Q1 2024 Earnings Report
Northwest Biotherapeutics Appoints Pat Sarma as Class II Director